Anionic Micelles and Vesicles Induce Tau Fibrillization in Vitro*

Carmen N. Chirita {ddagger} § , Mihaela Necula {ddagger} §  and Jeff Kuret § ||

From the {ddagger}Biophysics Program and §Department of Molecular and Cellular Biochemistry, The Ohio State University College of Medicine and Public Health, Columbus, Ohio 43210

Received for publication, February 17, 2003 , and in revised form, April 28, 2003.


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Alzheimer's disease is defined in part by the intraneuronal accumulation of filaments comprised of the microtubule-associated protein tau. In vitro, fibrillization of recombinant tau can be induced by treatment with various agents, including phosphotransferases, polyanionic compounds, and fatty acids. Here we characterize the structural features required for the fatty acid class of tau fibrillization inducer using recombinant full-length tau protein, arachidonic acid, and a series of straight chain anionic, cationic, and nonionic detergents. Induction of measurable tau fibrillization required an alkyl chain length of at least 12 carbons and a negative charge consisting of carboxylate, sulfonate, or sulfate moieties. All detergents and fatty acids were micellar at active concentrations, due to a profound, taudependent depression of their critical micelle concentrations. Anionic surfaces larger than detergent micelles, such as those supplied by phosphatidylserine vesicles, also induced tau fibrillization with resultant filaments originating from their surface. These data suggest that anionic surfaces presented as micelles or vesicles can serve to nucleate tau fibrillization, that this mechanism underlies the activity of fatty acid inducers, and that anionic membranes may serve this function in vivo.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Alzheimer's disease is a progressive neurodegenerative disease characterized in part by a constellation of intracellular neurofibrillary lesions termed neurofibrillary tangles, neuritic plaques, and neuropil threads (1). Each manifestation of neurofibrillary pathology is comprised of tau protein polymerized into filaments. Because neurofibrillary lesions appear with a stereotypic spatial distribution (2, 3) and correlate with both neuronal cell loss (4) and cognitive decline (5), they are useful markers of degeneration in Alzheimer's disease and other dementias.

There is much interest, therefore, in identifying cellular components that initiate tau filament formation in disease. Fibrillization of recombinant, full-length tau protein in vitro does not occur spontaneously at physiological concentrations (6). However, tau protein can be induced to fibrillize by changes in its primary structure (7) or its state of posttranslational modification (8, 9); by the addition of polyanionic substances such as sulfated glycosaminoglycans (heparin, dextran sulfate, and pentosan polysulfate) (1012), polyglutamate (11), and RNA (13); or by addition of fatty acids (14). Of these, fatty acids are especially efficacious in promoting the fibrillization of full-length tau protein at near physiological pH, temperature, reducing environment, ionic strength, and tau protein concentration (14, 15).

Nonetheless, the mechanism by which fatty acids induce tau fibrillization is unkown. Fatty acids resemble detergents in having hydrophobic alkyl chains and charged (anionic) head groups. Above their critical micelle concentrations (CMCs)1 in aqueous solution, fatty acids form micelles in which their hydrophobic moieties are sequestered, and their charged head groups are exposed to solvent. We (6) and others (16) have argued that the behavior of fatty acids such as arachidonic acid in assays of tau aggregation was consistent with it acting in micellar form. Yet fatty acids induce tau fibrillization at concentrations well below their measured CMC values (14). As free monomers, fatty acids have been shown to reversibly bind proteins through specific high-affinity motifs (17). Although such motifs have been suggested to exist in {alpha}-synuclein (18), a protein that forms amyloid filaments in Parkinson's disease (1921), they have not been found in human tau protein.

Here we examine the importance of alkyl chain length, chemical nature of the charged head group, and CMC for induction of tau polymerization using arachidonic acid, a series of ionic and nonionic synthetic detergents, and the anionic lipid phosphatidylserine. The results show that fatty acids induce tau fibrillization in micellar form without stoichiometric incorporation into filaments. The micelles must be negatively charged to promote fibrillization of full-length tau protein and, in the case of alkyl sulfate detergents, must contain at least 38 mol % negatively charged species. Because anionic lipids also induce tau fibrillization, it is proposed that intracellular membranes represent a class of physiologically relevant, intracellular tau polymerization inducers.


    EXPERIMENTAL PROCEDURES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Materials—Recombinant, His-tagged tau protein (htau40) was purified as described previously (22). Arachidonic acid (AA) and [14C]AA (55 Ci/mol) were obtained from Cayman Chemicals (Ann Arbor, MI) and American Radiolabeled Chemicals (St. Louis, MO), respectively, and stored at –80 °C under argon. Palmitoleic and stearic acids were from Sigma. Alkyl sulfate detergents (12–20 carbons) were obtained from Mallinckrodt (Paris, KY), Acros Organics (Morris Plains, NJ), Lancaster Synthesis (Pelham, NH), and Research Plus (Bayonne, NJ) as sodium salts. Alkyl sulfonate detergents (6–18 carbons) were obtained as sodium salts from Research Plus. Nonionic and cationic detergents (bromide salts) were purchased from Sigma (C10E8, C12E23, C14E8, and C21H46BrN), and Fluka (Milwaukee, WI; C8E4, C10E6, C19H42BrN, and C15H34BrN). Porcine brain L-{alpha}-phosphatidylserine (containing mostly 18:0 and 18:1 fatty acid chains) was from Avanti Polar-Lipids (Alabaster, AL). All detergent stock solutions were prepared in water, Me2SO, or 1:1 water:isopropanol and stored at –20 °C. N-Phenyl-1-naphthylamine was from Sigma.

Tau Polymerization Assays—Under standard conditions, htau40 (4–8 µM) was incubated with AA or other polymerization inducers (1–500 µM) in Assembly Buffer (10 mM HEPES, pH 7.4, 100 mM NaCl, and 5 mM dithiothreitol) at either room temperature or 37 °C for 3–6 h. Samples were processed for electron microscopy, fluorescence spectroscopy, or ultracentrifugation as described below.

Electron Microscopy—Aliquots of tau polymerization reactions were taken, treated with 2% glutaraldehyde (final concentration), mounted on formvar/carbon-coated 300 mesh grids, and negatively stained with 2% uranyl acetate as described previously (6). Images were viewed in a Phillips CM 12 transmission electron microscope operated at 65 kV. Random images were captured on film at x8,000 to x22,000 magnification, digitized at 600 dots-per-inch resolution, and imported into Optimas 6.5.1 for quantification of filament lengths and numbers (6). Individual filaments were defined as any object greater than 50 nm in its long axis and were counted manually.

Ultracentrifugation—Tau polymerization reactions were centrifuged (400,000 x g, 30 min) in an Optima TLX ultracentrifuge (TLA 100.2 rotor). The resultant pellets were washed three times with Assembly Buffer and then dissolved in 5% C12H25SO4Na containing 0.01 M NaOH. The amount of protein in the supernatant and pellet fractions was determined by the Coomassie Blue binding method (23) using purified, recombinant htau40 as standard.

Arachidonic Acid Binding Stoichiometry—Tau protein (8 µM) was subjected to polymerization as described above, except that AA was 14C-radiolabeled at a final specific activity of 25 Ci/mol. Reaction products were subjected to ultracentrifugation, and aliquots of the resultant supernatants and resuspended pellets were assayed for protein and [14C]AA by scintillation spectroscopy.

CMC Measurements—Detergents or lipids suspended in Assembly Buffer at varying concentrations (1 µM to 10 mM) were incubated for 1 h (at 37 °C or room temperature) in the presence of 10 µM N-phenyl-1-naphthylamine, after which fluorescence intensity was read directly in a PTI fluorimeter ({lambda}ex = 346 nm, {lambda}em = 420 nm, 1 nm bandwidth, 800 V, gain 12.5, and slit 16) jacketed at 37 °C. When present, htau40 was maintained at 4 µM. CMCs were estimated from abscissa intercepts after least squares linear regression as described previously (24) and expressed as CMC ± S.E. of the estimate. Only data points within 5-fold of the CMC were used to calculate CMC.

CMC values for alkyl sulfate detergents in water at 40 °C were calculated as described previously (25).

Liposome and Mixed Micelle Preparations—Phosphatidylserine was dissolved in chloroform at 1 mM, dried under a stream of argon (10 min), and dried by vacuum desiccation (45 min). Dried samples were hydrated at 1 mM concentration in Assembly Buffer by bath sonication in a Parafilm sealed glass test tube for 3 h. Liposomes were prepared fresh for each experiment, and their presence was confirmed by electron microscopy.

Mixed detergent micelles were prepared by mixing varying ratios of C14E8 and C20H41SO4Na at 2 mM total concentration followed by 30 min of sonication. Fibrillization reactions were performed as described above with 100 µM total final detergent concentration.

Nomenclature—Polyoxyethylene detergents of formula CH3(CH2)y-O(CH2CH2) x-H are referred to as C(y+1)Ex, where y and x are the number of methylene and oxyethylene groups, respectively. Sodium alkyl sulfate and alkyl tetramethyl ammonium bromide detergents are referred to by their chemical formulas.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Anionic but not Nonionic or Cationic Detergents Can Induce Tau Protein Assembly—The importance of alkyl chain length, head group charge, and CMC for induction of recombinant htau40 polymerization was examined for a selection of ionic and nonionic synthetic detergents. htau40 was used because of ease and yield of preparation and because the presence of the tag does not significantly change the rate or extent of AA-induced tau fibrillization (26). Nonionic detergents tested included the polyoxyethylenes Triton X-100 (data not shown), Tween 20, C8E4, C10E6, C10E8, C12E23, and C14E6. These had CMC values ranging from 10 to 600 µM when measured under standard tau assembly conditions in the presence or absence of htau40 (Table I). None of the nonionic detergents were capable of inducing tau fibrillization (using the transmission electron microscopy assay) when tested at concentrations up to 500 µM. In addition, tau protein had no observable effect on detergent micellization (Table I). These results suggest that uncharged surface active hydrophobic agents were insufficient to promote tau fibrillization when present in either dispersed or micellar form.


View this table:
[in this window]
[in a new window]
 
TABLE I
Detergent CMC values measured at 37 °C

 

Extending the analysis to cationic detergents C15H34BrN, C19H42BrN, and C21H46BrN revealed that they too were inactive as fibrillization inducers when assayed above or below their CMC, although the presence of tau protein modestly depressed the CMC for C19H42BrN (Table I). These data suggest that, like nonionic detergents, positively charged ionic detergents are incapable of inducing tau fibrillization in either dispersed or micellar form.

In contrast to these results, AA, which shares chemical properties with anionic detergents, was a powerful inducer of tau fibrillization at 75 µM concentration (Fig. 1). To determine whether other negatively charged chemical groups could substitute for the carboxylic acid moiety found in AA, the analysis was extended to include synthetic alkyl sulfate and alkyl sulfonate detergents containing 12–20 saturated straight chain carbon atoms. Very few filaments of long length (≥500 nm; 1–4 filaments/grid) were observed in the electron microscope when using the 12- or the 14-carbon sulfate or sulfonate series detergents as inducers. In contrast, alkyl sulfate and sulfonate detergents containing 16, 18, and 20 carbons induced significant polymerization. C18H37SO4Na and C20H41SO4Na were the most active inducers among this series; therefore, they were used in the studies described below. They produced abundant straight filaments from recombinant htau40 that were morphologically similar to those induced by AA (Fig. 1). Moreover, the alkyl sulfate detergents were broadly similar to AA in potency, yielding biphasic dose-response curves with maximal filament mass yielded at concentrations between 50 and 150 µM (Fig. 2). Nonetheless, alkyl sulfate inducers differed quantitatively from AA in that they appeared to be weaker nucleating agents, producing a smaller number of filaments that achieved longer length (Fig. 1). This was apparent in filament length distributions, which remained exponential but skewed toward longer lengths when induced by alkyl sulfates (Fig. 3). For example, AA produced >10-fold more filaments than C20H41SO4Na that were on average >5-fold shorter in length. Overall, despite inducing far fewer filaments, the total mass of filaments formed from C20H41SO4Na was typically {approx}75% of the mass induced by AA. These data suggest that AA and the alkyl sulfate detergents induce tau fibrillization by similar mechanisms and that the minimum structural features responsible for measurable inducer activity are an alkyl chain of at least 16 carbons in length and a negatively charged head group comprised of at least carboxylate, sulfate, or sulfonate moieties.



View larger version (53K):
[in this window]
[in a new window]
 
FIG. 1.
Alkyl sulfates induce tau fibrillization. Htau40 (4 µM) was incubated (3 h at 37 °C) in the presence of 75 µM (A) AA, (B) C20H41NaSO4, or (C) C18H37NaSO4 and then examined by transmission electron microscopy at x8,000 magnification. AA and both alkyl sulfate detergents induced straight filaments, which differed in number and length with each inducer. Bar, 500 nm.

 


View larger version (22K):
[in this window]
[in a new window]
 
FIG. 2.
Alkyl sulfates resemble AA in potency. Htau40 (4 µM) was incubated (3 h at 37 °C) in the presence of varying concentrations of AA ({blacksquare}), C18H37SO4Na (•), or C20H41SO4Na ({circ}) and then examined by transmission electron microscopy at x22,000 magnification. Filaments from two negatives were measured, summed, and plotted as total filament length ± range.

 


View larger version (19K):
[in this window]
[in a new window]
 
FIG. 3.
Length distributions of AA and alkyl sulfate-induced tau filaments. Htau40 (4 µM) was incubated (3 h at 37 °C) in the presence of 75 µM AA ({blacksquare}), C18H37SO4Na (•), and C20H41SO4Na ({circ}) and then examined by transmission electron microscopy at x8,000 magnification. The lengths of all filaments ≥ 50 nm in length were then measured from digitized images and plotted. Each data point represents the percentage of all analyzed filaments (totaling 1,580, 2,067, and 591 for AA, C18H37SO4Na, and C20H41SO4Na, respectively) that segregated into consecutive length intervals (100 nm bins), whereas each line represents the best fit of the data points to an exponential distribution. Although exponential distributions were observed for all inducers at 75 µM, C18H37SO4Na and C20H41SO4Na induced fewer filaments that grew to longer lengths as compared with AA.

 

AA-induced Tau Fibrillization Requires Micelle Formation— CMC values for AA and alkyl sulfate detergents were measured to determine whether micelles were important for tau fibrillization activity. Consistent with earlier observations (14), the CMC for AA in Assembly Buffer alone was measured as 236 ± 12 µM, which was well above the concentration required for tau fibrillization. When CMC was measured in Assembly Buffer complete with htau40 at 4 µM, however, the CMC decreased to 8.1 ± 0.5 µM. Tau-mediated CMC depression was observed with other fatty acids as well (palmitoleic and stearic acids; Table I), indicating that the effect was not unique to AA and extended to both saturated and unsaturated fatty acids. These data show that fatty acids aggregate to form micelles at a much lower concentration in the presence of htau40 than in its absence. CMC depression was apparent even at substoichiometric molar ratios of htau40 to fatty acid.

These observations were extended to a series of alkyl sulfate detergents, which follow a log-linear relationship between CMC and alkyl chain length when analyzed in water (Fig. 4; Ref. 25). The slope of this relationship is proportional to the free energy contribution of transferring methylene groups from solvent to micelles (25). When measured in the presence of Assembly Buffer (without tau), the relationship between log CMC and alkyl chain length remained linear but was depressed toward lower CMCs (Fig. 4) because of the presence of neutral electrolyte (100 mM NaCl) in the buffer (27). When measured in Assembly Buffer complete with htau40, however, CMC values were depressed still further, so that they were fully 2 orders of magnitude below the values observed in water alone (Fig. 4). Plots of log CMC versus alkyl chain length remained linear under these conditions, with slopes that were statistically indistinguishable (95% confidence interval) from those obtained in Assembly Buffer alone (Fig. 4), suggesting that the detergent aggregates formed in the presence of tau protein resembled authentic micelles with respect to their free energies of formation.



View larger version (17K):
[in this window]
[in a new window]
 
FIG. 4.
CMC values for alkyl sulfate detergents. CMC values for alkyl sulfate detergents were determined (37 °C) in Assembly Buffer in the presence (•) and absence ({square}) of htau40 (4 µM) and compared with published reference values (25) calculated in water at 40 °C ({blacksquare}). Although all conditions confirmed an inverse log-linear relationship between alkyl chain length and CMC (solid lines), the presence of tau greatly lowered measured CMC values relative to water or buffer alone.

 

These data show that tau protein exerted a profound effect on the micellization of anionic detergents and that anionic micelles were present under all assembly conditions that yielded tau filaments. The observation that tau fibrillization was initially proportional to increasing detergent or fatty acid concentration above their true CMCs (Fig. 2), where micelle but not monomer concentration was increasing (28), suggests that tau fibrillization is proportional to the concentration of anionic detergent or fatty acid micelles.

Minimum Requirements for Micelle-mediated Tau Fibrillization—To quantify the importance of negative charge for tau fibrillization, htau40 was incubated with mixed micelles prepared from nonionic detergent C14E8 and varying mol % concentrations of ionic inducer C20H41SO4Na. C14E8 was chosen as carrier because it was incapable of inducing tau fibrillization on its own and because, under assembly conditions, its had a low micromolar CMC, regardless of whether htau40 was present (Table I). Total detergent concentration was held constant at 100 µM to ensure the presence of micelles under all assay conditions, and resultant total filament mass was estimated by assaying tau protein in pellet and supernatant fractions after ultracentrifugation. Tau aggregation was not detectable below 20 mol % C20H41SO4Na but was observed at 40 mol % and increased above that concentration to 100 mol % C20H41SO4Na (Fig. 5). At that point, 39% of total tau protomer was rendered insoluble. Assuming a linear relationship between C20H41SO4Na content and tau filament formation and extrapolating to the ordinate intercept, tau fibrillization was supported under standard conditions when 100 µM mixed micelles contained 38.0 ± 6.4 mol % C20H41SO4Na.



View larger version (14K):
[in this window]
[in a new window]
 
FIG. 5.
Dependence of tau fibrillization on anionic micelles. Tau fibrillization was induced by incubation of htau40 (4 µM) with mixed micelles (100 µM detergent) prepared from nonionic detergent C14E8 and varying mol % C20H41SO4Na. The percentage of total tau mass recovered in the pellet fraction after ultracentrifugation (30 min, 400,000 x g) was measured and expressed as average percentage recovery ± S.D. of replicate experiments. Data points between 40 and 100 mol % C20H41SO4Na were fit by least squares linear regression (solid line). This line intersected the abscissa at 38.0 ± 6.4 mol %, yielding an estimate of the minimum concentration of C20H41SO4Na required to support tau fibrillization.

 

Phosphatidylserine Liposomes Induce Tau Polymerization—To determine whether anionic lipids could substitute for anionic detergents as inducers of tau fibrillization, htau40 was incubated (3 h at 37 °C) with 10–400 µM phosphatidylserine vesicles under standard conditions and subjected to electron microscopy assay. Unlike anionic micelles, phosphatidylserine vesicles were readily observable in electron microscopy assays because of their large size (typically >50 nm in diameter compared with <10 nm in diameter for detergents). Moreover, their CMCs in aqueous solution have been estimated in the nanomolar range (29), so that they were almost completely vesicular before incubation with tau protein. Examination of reaction products by electron microscopy showed the presence of vesicles and very long filaments at most phosphatidylserine concentrations tested. Closer inspection revealed that at least 15% of all filaments were associated with phospholipid vesicles through their ends, which appeared to extend from the vesicle surface (Fig. 6). Other vesicles were observed alone or associated with filaments along their length (Fig. 6). These data showed that anionic vesicle-forming lipids were capable of inducing tau filament formation and suggested that the mechanism involved facilitation of tau aggregation at the vesicle surface.



View larger version (115K):
[in this window]
[in a new window]
 
FIG. 6.
Stimulation of tau fibrillization by anionic lipid. Htau40 (4 µM) was incubated (3 h at 37 °C) with preformed phosphatidylserine vesicles and then examined by transmission electron microscopy (x22,000 magnification). Vesicles were observed as bodies > 50 nm in diameter (arrows) that were frequently associated with filaments. Approximately 15% of well-resolved filaments were found extending from the surface of vesicles (asterisks). Bar, 100 nm.

 

AA-mediated Tau Fibrillization Follows a Ligand-facilitated Mechanism—To test this hypothesis, htau40 was subjected to fibrillization conditions for 3.5 h in the presence and absence of [14C]AA (75 µM), and the amount of labeled AA comigrating with filamentous tau was determined after centrifugation. Under these conditions, ~50% of AA-treated htau40 comigrated with the pellet (filamentous) fraction, whereas most AA (>97%) remained in the soluble fraction (Table II). The pellet fraction contained 0.19 ± 0.05 mol AA/mol tau, confirming that AA remained at least partially associated with tau filaments but was not incorporated with 1:1 molar stoichiometry with respect to tau protomer. These data suggest that AA acted in micellar form to facilitate tau aggregation but did not directly mediate filament extension with concomitant incorporation into growing filaments.


View this table:
[in this window]
[in a new window]
 
TABLE II
Association of [14C]AA with tau filaments after centrifugation

 


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Here we examined the mechanism of fatty acid-mediated tau fibrillization and showed that it stems from two structural features: (a) an alkyl chain of at least 12 carbons in length, and (b) a negatively charged head group. Although requirement of an alkyl chain has been reported previously (14), its role has been confounding because all fatty acids examined to date have been active well below their CMCs, suggesting that alkyl chains were involved in binding tau protein rather than micellization. Published CMC values were determined in the absence of tau protein, however, and the surprising finding here is that the presence of even micromolar concentrations of tau protein greatly depressed the CMC for AA and other anionic detergents. Protein-mediated depression of alkyl sulfate CMC has been observed previously with micromolar concentrations of peptides derived from uteroglobin (30) and results from electrostatic interactions between positively charged amino acid side chains and negatively charged fatty acids or detergents. Indeed, a single pendent alkylamine (grossly resembling a Lys residue when protonated) attached to a neutral analyte such as polyethyleneglycol can depress the CMC for fatty acids by an order of magnitude (31). The htau40 construct used here contained a total of 59 Lys and Arg residues and a predicted net charge of +3.51 at assay pH (pH 7.4). Because htau40 had no effect on the CMC of nonionic detergents, it does not appear to depress CMC by modulating solvent surface tension (32). In any event, AA and anionic detergents are mostly micellar at 100 µM in the presence of tau protein. Inducer activity appears to reside with the micelle because incubation of tau with preformed micelles or lipid vesicles results in tau fibrillization. Moreover, tau filament yield initially increases with detergent concentration above the CMC, which corresponds to an increase in micelle but not detergent monomer concentration (28). Therefore, it is concluded that the principal role of the alkyl chain is to support micellization, and micelle formation in the 50–100-µM range in vitro requires an alkyl chain of at least 12 carbons. The alkyl moiety can be saturated (14) or unsaturated (this work and Ref. 14) and can be part of fatty esters such as phospholipids (this work).

Inducer activity also requires an ionizable head group, with sulfate, sulfonate, and carboxylate moieties all supporting tau fibrillization, even when presented as part of a phospholipid head group, as in the case of phosphatidylserine. The resultant negative charges appear to supply more than simple amphiphilic character to promote micelle formation because cationic detergents of similar alkyl chain length and CMC do not support tau fibrillization. Micelle-forming nonionic detergents and uncharged methyl or ethyl esters of AA (14) also are inactive. Therefore, it appears that the key role of ionizable groups is to present a negatively charged surface on the micelle.

Anionic micelles may induce filament formation by concentrating the basic tau protein molecules close to their surface, such that the energy barrier for nucleation is overcome (6, 14). Similar mechanisms have been postulated for the polyanion class of inducers, including heparin, poly-glutamate, nucleic acids, and the microtubule surface (1013, 33, 34). Alternatively, or in addition, filament formation could stem from micelle-dependent stabilization of assembly-competent protein conformations (35). Indeed, protein conformation alterations have been suggested to underlie observed differences in the ability of protein kinases to phosphorylate tau in the absence or presence of phospholipid liposomes (36). Regardless of its effects, micelle-tau association appears to be reversible because only ~15% of mature filaments were found associated with liposomes and because of the poor recovery of [14C]AA when tau filaments were isolated by sedimentation.

Although all alkyl sulfate detergents examined form micelles above their CMCs, their efficacy in promoting tau fibrillization under conditions reported here varied widely. For example, 12- and 14-carbon alkyl sulfates are extremely weak inducers and yield insufficient filaments to quantify by current assay methods. Significant quantities of filaments can be observed by electron microscopy using C16H33SO4Na, with C18H37NaSO4 and C20H41NaSO4 inducing large amounts of filaments. Because the degree of ionization of alkyl sulfate micelles is independent of aggregation number and salt concentration (37), it is unlikely that micelle charge varies with increasing alkyl chain length to influence anionic detergent efficacy. In contrast, micelle aggregation number does increase exponentially with alkyl chain length (38) and can lead to major differences in micelle size and shape. Extrapolating this relationship to C16H33SO4Na predicts an aggregation number of ~250 molecules/micelle near the CMC in solutions containing 100 mM NaCl (38). This corresponds to a radius less than half the hydrodynamic radius of monomeric tau protein (39). Efficient induction of tau fibrillization above this size may be related to micelle curvature, surface area, or volume. Although not demonstrated for tau protein, other amyloid-forming proteins such as A{beta}, prion protein, apolipoprotein C-III, and {alpha}-synuclein can obliquely insert into lipid membranes in a viral peptide fashion (4044), and this may contribute to their lipid-dependent aggregation (4551). Thus, the size of the hydrophobic micelle core may play a role in favoring polymerization-prone conformations of partially inserted proteins. Finally, it is noted that the large differences in aggregation number among alkyl sulfate detergents give rise to vastly different relationships between micelle and total detergent concentrations. This consideration may underlie the higher potency of C18H37NaSO4 relative to C20H41NaSO4 (Fig. 2), even though its CMC is greater. It may also limit the apparent efficacy of the smaller alkyl sulfate detergents by greatly narrowing the concentration range over which they are active (see the discussion of biphasic behavior below). Further experimentation will be necessary to determine which of these considerations is most important for differences in alkyl sulfate efficacy.

Although polyanions have emerged as useful tools in vitro, their structures have not pointed toward a clear cellular agent that would serve to promote tau fibrillization in disease. For example, RNA is present at high concentration inside of cells, but it is heavily complexed with protein and presumably not available in free form in sufficient amounts to induce tau filament formation (52). Similarly, heparan sulfate proteoglycans are extracellular and sequestered from the bulk of physiological tau protein. In contrast, the activity of anionic micelles and vesicles points toward cellular membranes as naturally abundant intracellular sources of clustered negative charge. Studies with Alzheimer's disease tissue show that hyperphosphorylated tau colocalizes with lipid rafts (53) and that tau filaments appear in association with cytomembranes (54). In fact, membrane association may be a normal function of tau because it has been shown to occur upon heterologous expression in PC12 cells (55) and may be mediated by electrostatic interaction with anionic lipids. Phosphatidylserine, the most abundant anionic phospholipid, comprises between 10 and 20 mol % of total phospholipid in cell membranes (56). Because phosphatidylserine is distributed primarily on the cytoplasmic face of cellular membranes (57), substantial negative charge is potentially available for binding tau protein. Using purified components, we found that fibrillization of htau40 required at least 38 mol % anionic charge in vitro. These results suggest that whereas phospholipid membranes are potential sites of tau aggregation in vivo, normal levels of anionic phospholipids may not be sufficient to drive fibrillization. Rather, increased levels of anionic lipids (58, 59), increased free tau concentration, or fibrillization-promoting changes such as hyperphosphorylation may be required for them to serve this pathological function. We note that individual tau isoforms differ in their aggregation properties (26), and hence the minimum charge content required for assembly of the mixtures of tau isoforms found in vivo will likely differ from the value determined here for htau40 alone.

Fatty acids have been especially useful agents for studying tau polymerization because of their efficacy with full-length tau protein under near-physiological conditions (6, 26). Moreover, as shown here, tau filaments nucleated with anionic vesicles (and presumably anionic micelles) morphologically resemble tau filaments extending from cellular membranes observed in biopsy specimens of authentic Alzheimer's disease brain (compare Fig. 6 herein with Fig. 2 of Ref. 54), suggesting that lipid-induced tau fibrillization models an authentic pathological process. Yet the method has disadvantages. First is the susceptibility of unsaturated fatty acids such as AA to oxidation, which modulates their activity and eventually renders them inert (60). Although alkyl sulfates induce fewer filaments than AA, they are more water-soluble, stable, and cheaper and thus provide convenient alternatives for in vitro polymerization reactions. A second disadvantage has been the unusual kinetics associated with AA-induced tau fibrillization. It has been postulated that this results from association of preformed micelles with tau (16). But from the work presented herein, it is now clear that the rapid initial time-course of reaction (which has been modeled as a two-phase exponential reaction; Ref. 6) and cooperative AA dependence (6, 60) result from two simultaneous reactions: (a) tau promoting the cooperative micellization of initially dispersed AA, and (b) AA micelles promoting the fibrillization of tau. Moreover, the biphasic nature of the AA concentration dependence (this work and Ref. 6) likely results from increasing concentrations of micelles binding increasing proportions of total tau monomer, thereby inhibiting filament extension and, eventually, nucleation. Replacement of fatty acids with alkyl sulfates will not change these latter characteristics.

In summary, we have shown that arachidonic acid promotes tau fibrillization in micellar form and can be replaced by anionic detergents or phospholipids. The data suggest that anionic membranes are candidate nucleation centers in vivo.


    FOOTNOTES
 
* This work was supported by National Institutes of Health Grant AG14452 (to J. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

Both authors contributed equally to this work. Back

|| To whom correspondence should be addressed: Center for Biotechnology, 1060 Carmack Rd., Columbus, OH 43210. Tel.: 614-688-5899; Fax: 614-292-5379; E-mail: kuret.3{at}osu.edu.

1 The abbreviations used are: CMC, critical micelle concentration; AA, arachidonic acid. Back


    ACKNOWLEDGMENTS
 
We thank Dr. Robert Lee (Ohio State University College of Pharmacy) for guidance in liposome preparation and Drs. T. Chris Gamblin and Aida Abraha (Northwestern University Medical School) for guidance with electron microscopy methods.



    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Trojanowski, J. Q., Shin, R. W., Schmidt, M. L., and Lee, V. M. (1995) Neurobiol. Aging 16, 335–340[CrossRef][Medline] [Order article via Infotrieve]
  2. Feany, M. B., and Dickson, D. W. (1996) Ann. Neurol. 40, 139–148[Medline] [Order article via Infotrieve]
  3. Braak, H., and Braak, E. (1991) Acta Neuropathol. 82, 239–259[Medline] [Order article via Infotrieve]
  4. Gomez-Isla, T., Price, J. L., McKeel, D. W., Jr., Morris, J. C., Growdon, J. H., and Hyman, B. T. (1996) J. Neurosci. 16, 4491–4500[Abstract/Free Full Text]
  5. Ghoshal, N., Garcia-Sierra, F., Wuu, J., Leurgans, S., Bennett, D. A., Berry, R. W., and Binder, L. I. (2002) Exp. Neurol. 177, 475–493[CrossRef][Medline] [Order article via Infotrieve]
  6. King, M. E., Ahuja, V., Binder, L. I., and Kuret, J. (1999) Biochemistry 38, 14851–14859[CrossRef][Medline] [Order article via Infotrieve]
  7. von Bergen, M., Barghorn, S., Li, L., Marx, A., Biernat, J., Mandelkow, E. M., and Mandelkow, E. (2001) J. Biol. Chem. 276, 48165–48174[Abstract/Free Full Text]
  8. Alonso, A., Zaidi, T., Novak, M., Grundke-Iqbal, I., and Iqbal, K. (2001) Proc. Natl. Acad. Sci. U. S. A. 98, 6923–6928[Abstract/Free Full Text]
  9. Sato, S., Tatebayashi, Y., Akagi, T., Chui, D. H., Murayama, M., Miyasaka, T., Planel, E., Tanemura, K., Sun, X., Hashikawa, T., Yoshioka, K., Ishiguro, K., and Takashima, A. (2002) J. Biol. Chem. 277, 42060–42065[Abstract/Free Full Text]
  10. Goedert, M., Jakes, R., Spillantini, M. G., Hasegawa, M., Smith, M. J., and Crowther, R. A. (1996) Nature 383, 550–553[CrossRef][Medline] [Order article via Infotrieve]
  11. Friedhoff, P., Schneider, A., Mandelkow, E. M., and Mandelkow, E. (1998) Biochemistry 37, 10223–10230[CrossRef][Medline] [Order article via Infotrieve]
  12. Hasegawa, M., Crowther, R. A., Jakes, R., and Goedert, M. (1997) J. Biol. Chem. 272, 33118–33124[Abstract/Free Full Text]
  13. Kampers, T., Friedhoff, P., Biernat, J., Mandelkow, E. M., and Mandelkow, E. (1996) FEBS Lett. 399, 344–349[CrossRef][Medline] [Order article via Infotrieve]
  14. Wilson, D. M., and Binder, L. I. (1997) Am. J. Pathol. 150, 2181–2195[Abstract]
  15. Khatoon, S., Grundke-Iqbal, I., and Iqbal, K. (1992) J. Neurochem. 59, 750–753[Medline] [Order article via Infotrieve]
  16. Barghorn, S., and Mandelkow, E. (2002) Biochemistry 41, 14885–14896[CrossRef][Medline] [Order article via Infotrieve]
  17. Schroeder, F., Jolly, C. A., Cho, T. H., and Frolov, A. (1998) Chem. Phys. Lipids 92, 1–25[CrossRef][Medline] [Order article via Infotrieve]
  18. Sharon, R., Goldberg, M. S., Bar-Josef, I., Betensky, R. A., Shen, J., and Selkoe, D. J. (2001) Proc. Natl. Acad. Sci. U. S. A. 98, 9110–9115[Abstract/Free Full Text]
  19. Spillantini, M. G., Schmidt, M. L., Lee, V. M., Trojanowski, J. Q., Jakes, R., and Goedert, M. (1997) Nature 388, 839–840[CrossRef][Medline] [Order article via Infotrieve]
  20. Serpell, L. C., Berriman, J., Jakes, R., Goedert, M., and Crowther, R. A. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 4897–4902[Abstract/Free Full Text]
  21. Conway, K. A., Harper, J. D., and Lansbury, P. T., Jr. (2000) Biochemistry 39, 2552–2563[CrossRef][Medline] [Order article via Infotrieve]
  22. Carmel, G., Mager, E. M., Binder, L. I., and Kuret, J. (1996) J. Biol. Chem. 271, 32789–32795[Abstract/Free Full Text]
  23. Bradford, M. M. (1976) Anal. Biochem. 72, 248–254[CrossRef][Medline] [Order article via Infotrieve]
  24. Brito, R. M., and Vaz, W. L. (1986) Anal. Biochem. 152, 250–255[Medline] [Order article via Infotrieve]
  25. Huibers, P. D. T., Lobanov, V. S., Katritzky, A. R., Shah, D. O., and Karelson, M. (1997) J. Colloid Interface Sci. 187, 113–120[CrossRef][Medline] [Order article via Infotrieve]
  26. King, M. E., Gamblin, T. C., Kuret, J., and Binder, L. I. (2000) J. Neurochem. 74, 1749–1757[CrossRef][Medline] [Order article via Infotrieve]
  27. Corrin, M. L., and Harkins, W. D. (1947) J. Am. Chem. Soc. 67, 683–688
  28. Gunnarsson, G., Jonsson, B., and Wennerstrom, H. (1980) J. Phys. Chem. 84, 3114–3121
  29. King, M. D., and Marsh, D. (1987) Biochemistry 26, 1224–1231[Medline] [Order article via Infotrieve]
  30. Tessari, M., Foffani, M. T., Mammi, S., and Peggion, E. (1993) Biopolymers 33, 1877–1887[Medline] [Order article via Infotrieve]
  31. Koyama, Y., Umehara, M., Mizuno, A., Itaba, M., Yasukouchi, T., Natsume, K., and Suginaka, A. (1996) Bioconjugate Chem. 7, 298–301[CrossRef][Medline] [Order article via Infotrieve]
  32. Ray, A. (1971) Nature 231, 313–315[Medline] [Order article via Infotrieve]
  33. Ackmann, M., Wiech, H., and Mandelkow, E. (2000) J. Biol. Chem. 275, 30335–30343[Abstract/Free Full Text]
  34. Perez, M., Valpuesta, J. M., Medina, M., Montejo de Garcini, E., and Avila, J. (1996) J. Neurochem. 67, 1183–1190[Medline] [Order article via Infotrieve]
  35. Davidson, W. S., Jonas, A., Clayton, D. F., and George, J. M. (1998) J. Biol. Chem. 273, 9443–9449[Abstract/Free Full Text]
  36. Baudier, J., and Cole, R. D. (1987) J. Biol. Chem. 262, 17577–17583[Abstract/Free Full Text]
  37. Bales, B. L. (2001) J. Phys. Chem. B 105, 6798–6804[CrossRef]
  38. Ranganathan, R., Tran, L., and Bales, B. L. (2000) J. Phys. Chem. B 104, 2260–2264[CrossRef]
  39. Cleveland, D. W., Hwo, S. Y., and Kirschner, M. W. (1977) J. Mol. Biol. 116, 207–225[Medline] [Order article via Infotrieve]
  40. Pillot, T., Goethals, M., Vanloo, B., Talussot, C., Brasseur, R., Vandekerckhove, J., Rosseneu, M., and Lins, L. (1996) J. Biol. Chem. 271, 28757–28765[Abstract/Free Full Text]
  41. Pillot, T., Lins, L., Goethals, M., Vanloo, B., Baert, J., Vandekerckhove, J., Rosseneu, M., and Brasseur, R. (1997) J. Mol. Biol. 274, 381–393[CrossRef][Medline] [Order article via Infotrieve]
  42. Lins, L., Flore, C., Chapelle, L., Talmud, P. J., Thomas, A., and Brasseur, R. (2002) Protein Eng. 15, 513–520[Abstract/Free Full Text]
  43. Volles, M. J., Lee, S. J., Rochet, J. C., Shtilerman, M. D., Ding, T. T., Kessler, J. C., and Lansbury, P. T., Jr. (2001) Biochemistry 40, 7812–7819[CrossRef][Medline] [Order article via Infotrieve]
  44. Voneche, V., Portetelle, D., Kettmann, R., Willems, L., Limbach, K., Paoletti, E., Ruysschaert, J. M., Burny, A., and Brasseur, R. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 3810–3814[Abstract]
  45. Choo-Smith, L. P., Garzon-Rodriguez, W., Glabe, C. G., and Surewicz, W. K. (1997) J. Biol. Chem. 272, 22987–22990[Abstract/Free Full Text]
  46. Terzi, E., Holzemann, G., and Seelig, J. (1995) J. Mol. Biol. 252, 633–642[CrossRef][Medline] [Order article via Infotrieve]
  47. Perrin, R. J., Woods, W. S., Clayton, D. F., and George, J. M. (2001) J. Biol. Chem. 276, 41958–41962[Abstract/Free Full Text]
  48. Lee, H. J., Choi, C., and Lee, S. J. (2002) J. Biol. Chem. 277, 671–678[Abstract/Free Full Text]
  49. Uversky, V. N., Lee, H. J., Li, J., Fink, A. L., and Lee, S. J. (2001) J. Biol. Chem. 276, 43495–43498[Abstract/Free Full Text]
  50. Cole, N. B., Murphy, D. D., Grider, T., Rueter, S., Brasaemle, D., and Nussbaum, R. L. (2002) J. Biol. Chem. 277, 6344–6352[Abstract/Free Full Text]
  51. Del Mar Martinez-Senac, M., Villalain, J., and Gomez-Fernandez, J. C. (1999) Eur. J. Biochem. 265, 744–753[Abstract/Free Full Text]
  52. Perez-Canadillas, J. M., and Varani, G. (2001) Curr. Opin. Struct. Biol. 11, 53–58[CrossRef][Medline] [Order article via Infotrieve]
  53. Yen, S., Ishizawa, T., Dickson, D., Yen, S. H., Boeve, B., Smith, G., Ivnik, R., and Petersen, R. (2002) Neurobiol. Aging 23, S490–S491
  54. Gray, E. G., Paula-Barbosa, M., and Roher, A. (1987) Neuropathol. Appl. Neurobiol. 13, 91–110[Medline] [Order article via Infotrieve]
  55. Bondareff, W., Matsuyama, S. S., and Dell'Albani, P. (1998) J. Neurosci. Res. 52, 498–504[CrossRef][Medline] [Order article via Infotrieve]
  56. Sun, G. Y., and Foudin, L. L. (1985) in Phospholipids in Nervous Tissues (Eichberg, J., ed), pp. 79–134, Wiley, New York
  57. Schlegel, R. A., and Williamson, P. (2001) Cell Death Differ. 8, 551–563[CrossRef][Medline] [Order article via Infotrieve]
  58. Wells, K., Farooqui, A. A., Liss, L., and Horrocks, L. A. (1995) Neurochem. Res. 20, 1329–1333[Medline] [Order article via Infotrieve]
  59. Farooqui, A. A., Rapoport, S. I., and Horrocks, L. A. (1997) Neurochem. Res. 22, 523–527[CrossRef][Medline] [Order article via Infotrieve]
  60. Gamblin, T. C., King, M. E., Dawson, H., Vitek, M. P., Kuret, J., Berry, R. W., and Binder, L. I. (2000) Biochemistry 39, 6136–6144[CrossRef][Medline] [Order article via Infotrieve]